Want to know more about generator based radiopharmaceuticals?

Generator-based theranostic radiopharmaceuticals represent a significant step toward expanding access to precision nuclear medicine. By providing on-demand production of clinically relevant radionuclides without requiring a nearby cyclotron or reactor, radionuclide generators have the potential to make both diagnostic imaging and targeted radionuclide therapy more widely available. Continued advances in generator technology, radiochemistry, and regulatory standards are expected to improve isotope purity, reliability, and scalability, supporting the development of next-generation theranostic agents for oncology and other diseases.